ロード中...
Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics
OBJECTIVE: Clinical trials demonstrate improving survival in patients with multiple myeloma (MM) after treatment. However, it is unclear whether increased survival translates to a similar benefit in a real world setting. METHODS: We analyzed the overall survival of 347 multiple myeloma patients in A...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777410/ https://ncbi.nlm.nih.gov/pubmed/26937956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0147381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|